Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Delayed arterial healing 5 years after implantation of sirolimus-eluting stents: no smoke without fire.
Nammas W.
Am Heart J. 2011 Nov;162(5):e29. Epub 2011 Sep 17. No abstract available.
Related citations
Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.
Gutiérrez-Chico JL, Jüni P, García-García HM, Regar E, Nüesch E, Borgia F, van der Giessen WJ, Davies S, van Geuns RJ, Secco GG, Meis S, Windecker S, Serruys PW, di Mario C.
Am Heart J. 2011 Nov;162(5):922-31. Epub 2011 Oct 7.
Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting.
Puymirat E, Mangiacapra F, Peace A, Sharif F, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.
Am Heart J. 2011 Nov;162(5):907-13. Epub 2011 Sep 22.
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial.
Tunggal P, Ng FH, Lam KF, Chan FK, Lau YK.
Am Heart J. 2011 Nov;162(5):870-4.
Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry).
Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK.
Am J Cardiol. 2012 Apr 1;109(7):941-6. Epub 2012 Jan 9.
Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Wallace EL, Abdel-Latif A, Charnigo R, Moliterno DJ, Brodie B, Matnani R, Ziada KM.
Am J Cardiol. 2012 Apr 1;109(7):932-40. Epub 2012 Jan 3. Review.
Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy.
Mehta RH, Parsons L, Peterson ED; National Registry of Myocardial Infarction Investigators.
Am J Cardiol. 2012 Apr 1;109(7):925-31. Epub 2012 Jan 3.
Predictors of ten-year event-free survival in patients with acute myocardial infarction (from the Adria, Bassano, Conegliano, and Padova Hospitals [ABC] study on myocardial infarction).
Berton G, Cordiano R, Cavuto F, Giacomini G, De Toni R, Palatini P.
Am J Cardiol. 2012 Apr 1;109(7):966-75. Epub 2012 Jan 3.
Comparison of the Diamond-Forrester method and Duke Clinical Score to predict obstructive coronary artery disease by computed tomographic angiography.
Wasfy MM, Brady TJ, Abbara S, Nasir K, Ghoshhajra BB, Truong QA, Hoffmann U, Di Carli MF, Blankstein R.
Am J Cardiol. 2012 Apr 1;109(7):998-1004. Epub 2012 Jan 9.
Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing.
Tsiachris D, Tsioufis C, Dimitriadis K, Syrseloudis D, Rousos D, Kasiakogias A, Papademetriou V, Tousoulis D, Stefanadis C.
Am J Cardiol. 2012 Apr 1;109(7):1026-30. Epub 2012 Jan 3.
Coronary artery disease in patients with psoriasis referred for coronary angiography.
Armstrong AW, Harskamp CT, Ledo L, Rogers JH, Armstrong EJ.
Am J Cardiol. 2012 Apr 1;109(7):976-80. Epub 2012 Jan 3.
Ankle-Brachial Index and Coronary Artery Lesion Complexity in Patients With Acute Coronary Syndromes.
Korkmaz L, Adar A, Erkan H, Agaç MT, Acar Z, Kurt IH, Akyuz AR, Bektas H, Celik S.
Angiology. 2012 Jan 10. [Epub ahead of print]
Left atrial expansion index for predicting atrial fibrillation and in-hospital mortality after coronary artery bypass graft surgery.
Wang WH, Hsiao SH, Lin KL, Wu CJ, Kang PL, Chiou KR.
Ann Thorac Surg. 2012 Mar;93(3):796-803. Epub 2012 Jan 5.
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.
Uchino K, Hernandez AV.
Arch Intern Med. 2012 Mar 12;172(5):397-402. Epub 2012 Jan 9. Review.
Dabigatran: do we have sufficient data?: comment on "Dabigatran association with higher risk of acute coronary events".
Jacobs JM, Stessman J.
Arch Intern Med. 2012 Mar 12;172(5):403-4. Epub 2012 Jan 9. No abstract available.
Important data after drug approval: comment on "Dabigatran association with higher risk of acute coronary events".
Redberg RF.
Arch Intern Med. 2012 Mar 12;172(5):404. Epub 2012 Jan 9. No abstract available.
Socioeconomic status, cardiovascular risk factors, and subclinical atherosclerosis in young adults: the cardiovascular risk in Young Finns Study.
Kestilä P, Magnussen CG, Viikari JS, Kähönen M, Hutri-Kähönen N, Taittonen L, Jula A, Loo BM, Pietikäinen M, Jokinen E, Lehtimäki T, Kivimäki M, Juonala M, Raitakari OT.
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):815-21. Epub 2012 Jan 5.
Urotensin-II signaling mechanism in rat coronary artery: role of STIM1 and Orai1-dependent store operated calcium influx in vasoconstriction.
Domínguez-Rodríguez A, Díaz I, Rodríguez-Moyano M, Calderón-Sánchez E, Rosado JA, Ordóñez A, Smani T.
Arterioscler Thromb Vasc Biol. 2012 May;32(5):1325-32. Epub 2012 Jan 5.
Risks of aspirin outweigh benefits in people without cardiovascular disease, shows analysis.
Mayor S.
BMJ. 2012 Jan 9;344:e241. doi: 10.1136/bmj.e241. No abstract available.
Outcomes of primary percutaneous coronary intervention for acute myocardial infarction with unprotected left main coronary artery occlusion.
Izumikawa T, Sakamoto S, Takeshita S, Takahashi A, Saito S.
Catheter Cardiovasc Interv. 2012 Jan 10. doi: 10.1002/ccd.23396. [Epub ahead of print]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on